MRI based Therapeutic Vectors
Journal of Medical Imaging · 2019
DOI: 10.31916/sjmi2019-01-01 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Imaging, 2019. Verfasst von SangBock Lee und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The development of simultaneous therapy and imaging systems (Theranostics) for microRNA (miRNA) is demanded the clinical application of RNA interference (RNAi) in cancer treatment and immune therapy. In this paper, we report a pH-sensitive, magnetic nanoparticle-based miRNA A delivery system that can enable the safe and effective delivery, imaging by high-resolution Magnetic Resonance Imaging (MRI) and therapeutic ability through regulating tumor metastasis and immune evasion via miRNA34a. Cationic poly-L-lysine-graft (PL) With a reactive silane moiety was stably immobilized onto the surface of the assembled manganese ferrite nanoparticles (MFs) through an emulsion process, ensuring high water solubility, enhanced MR contrast effect, and endosomolytic functionality. The MRI-based theranostic nanovectors (MNVs) were then complexed with miRNA34a via electrostatic interaction to verify the regulation for cancer metastasis by CD44 and immune avoidance by regulating PD-L1. These results showed a novel A platform for synergetic cancer therapy based on miRNA.
Zitieren
APA
Lee, S., & singh, V. R. (2019). MRI based Therapeutic Vectors. Journal of Medical Imaging. https://doi.org/10.31916/sjmi2019-01-01
Vancouver
Lee S, singh VR. MRI based Therapeutic Vectors. Journal of Medical Imaging. 2019. doi:10.31916/sjmi2019-01-01
BibTeX
@article{Lee2019,
author = {Lee, SangBock and singh, V. R.},
title = {MRI based Therapeutic Vectors},
journal = {Journal of Medical Imaging},
year = {2019},
doi = {10.31916/sjmi2019-01-01}
}
EUVIMED